Delivery Order SPE2DB22D3016-SPE2DB23FBSP5
Award Date 9/18/23
Potential Completion Date 9/19/23
Potential Value $511
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $68,100 firm fixed price delivery order to Amerisourcebergen Drug Corporation for Novolog 100 unit/ml FlexPen 3ml insulin injector pens. As a major pharmaceutical supplier to the Department of Defense, Amerisourcebergen will deliver the insulin pens from its Conshohocken, Pennsylvania distribution facility under the terms of the single day order. The award draws from DLA's prime vendor pharmaceutical contracts that provide medical supplies to support the...
- The Defense Logistics Agency awarded a $1,781.88 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 4562331403 Novolog 100 unit/ml FlexPen 3ml insulin delivery devices. The delivery order was issued under an existing prime vendor contract vehicle and calls for the delivery of the specified insulin pens to a facility located in Conshohocken, Pennsylvania by September 28, 2023. As a leading provider of medical supplies and pharmaceuticals to the Department of...
- The Defense Logistics Agency awarded a $238,280 firm fixed price delivery order to AmerisourceBergen Drug Corporation for the supply of 3,456 units of Novolog 100 unit/ml flexpens. The delivery order was issued under an existing prime vendor contract vehicle and calls for the delivery of the insulin pens to a facility in Conshohocken, Pennsylvania by September 19, 2023 to support the Department of Defense's medical supply needs. AmerisourceBergen will perform as the prime contractor, with no...
- The Defense Logistics Agency awarded a $3,676 delivery order to Amerisourcebergen Drug Corporation for 100 unit/ml Novolog Flexpen 3ml insulin devices. The firm fixed price order is being fulfilled from Amerisourcebergen's Conshohocken, Pennsylvania location to support Defense Department medical supply needs. As a major pharmaceutical supplier, Amerisourcebergen will deliver the contracted insulin devices to the DLA on behalf of its pharmaceutical distribution schedule contract, which enables...
- The Defense Logistics Agency awarded a $699.18 delivery order to Amerisourcebergen Drug Corp Corporate Office Division for 4561309676 Novolog 100 unit/ml Flexpen 3ml insulin injectors. The firm fixed price order is being fulfilled from the contractor's location in Conshohocken, Pennsylvania, with performance spanning June 21-22, 2023. As a leading supplier of pharmaceuticals and medical supplies to the Department of Defense, Amerisourcebergen is well positioned through existing contracts to...
- The Defense Logistics Agency awarded a $106,240 firm fixed price delivery order to Amerisourcebergen Drug Corporation for Novolog penfill insulin injector devices. As the prime contractor, Amerisourcebergen will supply 100 units per milliliter of the drug in 3 milliliter prefilled disposable insulin pens to support the Department of Defense's medical readiness and logistics needs. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one day period in late...
- The Defense Logistics Agency awarded a $204,240 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 4561490218 Novolog 100 unit/ml FlexPen 3ml insulin delivery devices. As a major supplier of pharmaceuticals and medical supplies to the Department of Defense through indefinite-delivery contracts, Amerisourcebergen will deliver the insulin pens to a location in Conshohocken, Pennsylvania within the one day period of performance specified between July 13-14,...
- The Defense Logistics Agency awarded a $408 delivery order to Amerisourcebergen Drug Corporation for 4561378006 Novolog 100 unit/ml Flexpen 3ml insulin delivery devices. The firm fixed price order is being fulfilled from the contractor's facility in Conshohocken, Pennsylvania, with performance spanning June 29-30, 2023. As a leading provider of pharmaceuticals and medical supplies, Amerisourcebergen will deliver the contracted insulin pens in support of the Defense Logistics Agency's mission...
- The Defense Logistics Agency awarded a $34,040 delivery order to Amerisourcebergen Drug Corporation for 4561696823 Novolog 100 unit/ml Flexpen 3ml insulin delivery devices. As a prime contractor for DLA's pharmaceutical supply chain programs, Amerisourcebergen will deliver the insulin pens from its facility in Conshohocken, Pennsylvania to an unspecified customer by August 4, 2023 under firm fixed pricing. The delivery order was issued against an existing DLA pharmaceutical supply vehicle to...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $1,225 to Amerisourcebergen Drug Corporation for the supply of 100 unit/ml Novolog Flexpen 3ml insulin delivery devices. As the prime contractor, Amerisourcebergen Drug Corporation will deliver the requested medical supplies to a location in Conshohocken, Pennsylvania by September 28, 2023 under the terms of the order. The Defense Logistics Agency routinely issues such requirements to Amerisourcebergen...
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB23FBSP5Delivery Order
The Defense Logistics Agency awarded a $510,600 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 4562217267 Novolog 100 unit/ml Flexpen 3ml insulin injectors. As a major distributor of pharmaceutical and medical supplies to the Department of Defense, Amerisourcebergen will deliver the insulin pens from its Conshohocken, Pennsylvania distribution center under a one-day period of performance concluding on September 19, 2023. The award was issued using the DLA's Pharmaceutical Prime Vendor contract, which provides medical materiel in support of the U.S. military healthcare system. No subcontractors or set-aside designations were identified.
Generated 12/18/23, 12:56 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $511 | 9/18/23 |